Advancing HIV Biomedical Prevention Research for At-Risk Adolescents.

ABSTRACT: Despite significant additions to the HIV prevention toolbox, infection rates across the United States continue to rise among vulnerable adolescents and young adults. Access to these interventions by youth at risk for HIV is limited by the lack of data about their safety and use, compounding the myriad contextual barriers to effectively preventing HIV in this group. The NIH-funded Adolescent Trials Network implemented an innovative approach to the inclusion of adolescents at risk for HIV infection who consented for their own participation in the first adolescent study of HIV pre-exposure prophylaxis (PrEP). This model of mature minor consent was supported by state-based adolescent treatment statutes that extend an adolescent's ability to consent to participation in research with a sufficien

SUBMITTER: Kapogiannis BG 

PROVIDER: S-EPMC6231953 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature